Detlef F. Albrecht

Detlef F. Albrecht

Chief Tech/Sci/R&D Officer at SATSUMA PHARMACEUTICALS, INC.
65 year
Health Technology
Consumer Services

Profile

Detlef F.
Albrecht
was the founder of Relypsa, Inc. founded in 2007, where he held the title of Chief Medical Officer & SVP-Research & Development.
Currently, he is the Chief Medical Officer at Satsuma Pharmaceuticals, Inc. since 2017.
Dr. Albrecht's former positions include President, Chief Executive Officer & Director at Sorbent Therapeutics, Inc., Senior Director-Clinical Development at Miravant Medical Technologies, Director-Clinical Development at Schwarz Pharma, Inc., Vice President-Clinical Development at ALZA Corp., Chief Medical Officer & Senior Vice President at IntraBiotics Pharmaceuticals, Inc., Chief Medical Officer, SVP-Research & Development at Ilypsa, Inc., and Chief Medical Officer & Head-Drug Development at Armetheon, Inc. Dr. Albrecht holds a doctorate degree from RWTH Aachen University.

Detlef F. Albrecht active positions

CompaniesPositionStart
SATSUMA PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 01/07/2017

Former positions of Detlef F. Albrecht

CompaniesPositionEnd
Chief Tech/Sci/R&D Officer 01/06/2017
Chief Tech/Sci/R&D Officer 02/01/2009
Chief Tech/Sci/R&D Officer 22/01/2007
ALZA CORPORATION Corporate Officer/Principal 01/01/2004
MIRAVANT MEDICAL TECHNOLOGIES INC. Corporate Officer/Principal 01/01/1999
See the detail of Detlef F. Albrecht's experience

Training of Detlef F. Albrecht

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

60

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Detlef F. Albrecht